Pharmaceutical Technology ePT Weekly
Having trouble viewing this e-mail? CLICK HERE
PharmTech
January 12, 2017
PHARMTECH.COM CURRENT ISSUE SUBSCRIBE FORWARD

In this issue

Pharma's R&D Dilemma

Takeda to Acquire ARIAD

Wockhardt Receives Warning Letter

Top Stories

Deficiencies in Manufacturing Derail CDER Approvals in 2016

The number of novel drugs approved in 2016 by FDA's CDER department was half the number approved the previous year; many of the complete response letters issued in 2016 were a result of preapproval inspection.
/ read more /


J&J Announces 15 New Collaborations

J&J's Innovation Global announced the company has entered into 15 new collaborations.
/ read more /

Subscribe

Subscribers can enjoy each full issue of Pharm Tech in print, or via Pharm Tech apps.

subscription offers
subscribe

PODCAST

B&W Tek's director of Market and Customer Development, Katherine A. Bakeev, PhD, discusses analysis of pharmaceutical raw materials and the benefits of using handheld Raman spectrometers.

WATCH NOW
advertisement

The 2017 PDA Pharmaceutical Quality Metrics and Quality Culture Conference, Feb. 21-22, presents the first opportunity to address the FDA's revised draft guidance on quality metrics. Through plenary sessions and panel discussions, industry and regulatory experts will explore what has changed in the FDA's newest guidance, the benefits to industry and patients, and potential challenges to implementation across various segments of the pharmaceutical industry. Learn more


Industry News

Do New Cancer Drugs Increase Overall Clinical Benefit?

A study of 53 cancer drugs found that new treatments extended patient life an average of 3.43 months when compared with treatments available in 2003.
/ read more /


Pharma's R&D Dilemma: Blockbuster Costs Without Blockbuster Revenues

According to a Deloitte report, the industry's return on its research investment has been steadily slipping for the past six years. The conclusion? Fundamental change may no longer be a given, but a necessity for the industry.
/ read more /


More Industry News

Supplier News

Catalent to Develop Softgels for Orphan Drug Candidate

Catalent announces a development agreement with JOT to evaluate softgel options for a resveratrol drug candidate.
/ read more /


Siemens and GEA Partner to Deliver Solid-Dosage Continuous Manufacturing

GEA's ConsiGma continuous tableting line combined with Siemens' automation and Sipat data management systems enables continuous manufacturing.
/ read more /


More Supplier News

advertisement

See machinery in action. Discover packaging innovations. Learn about breakthroughs and best practices. For pharma and medical device manufacturing professionals, PACK EXPO East and the Healthcare Packaging and Processing Conference have it all! Head to Philadelphia next month for solutions from 400+ exhibitors—including 200+ pharma industry suppliers—and get answers to critical issues from 30 education sessions. Register today at packexpoeast.com


Bio/Pharma News

Takeda to Acquire ARIAD

Takeda will acquire ARIAD Pharmaceuticals for approximately $5.2 billion.
/ read more /


Regeneron and Sanofi Ordered to Withdraw PCSK9 Inhibitor Praluent from Market

A judge ruled that Regeneron's mAb be removed from the market after Amgen alleged that the marketing of Praluent hurt its reputation as innovator of this class of drugs.
/ read more /


More Bio/Pharma News

Regulatory News

European Pharmacopoeia Publishes Chemical Imaging Chapter

The European Pharmacopoeia Commission adopted a chapter on chemical imaging for analytical development, quality control, and manufacturing.
/ read more /


Wockhardt Limited Receives FDA Warning Letter

The company was cited by FDA for violations of sterile processing GMPs.
/ read more /


More Regulatory News

advertisement

PARTICIPATE! Need your input for BioPlan's 14th Annual Global Biopharmaceutical Manufacturing Study - BioPlan will donate $10 (up to $2,000) on your behalf to global health charities - Be the first to receive a FREE Aggregated Summary of this year's results AND receive our UPDATED 15 Top Trends in Biopharmaceutical Manufacturing White Paper. Learn more


FEATURED TOPICS

QUALITY

Overcoming Low Endotoxin Recovery

Understanding of endotoxin assays and a range of detection technologies are essential for effective testing.
/ read more /

PEER-REVIEWED RESEARCH

Establishing Acceptance Limits for Uniformity of Dosage Units: Part 1

The Uniformity of Dosage Units test is used to evaluate content uniformity or weight variation or dosage forms such as tablets and capsules. The author introduces two different acceptance value limits (n = 10 and 30) in this article.
/ read more /

advertisement

Pharmaceutical Technology's PharmaMarketplace
Your Connection to Global Pharmaceutical Manufacturing Suppliers.
Check it out today!


API SYNTHESIS & MANUFACTURING

New Horizons for Cross-Coupling Reactions

Non-precious-metal catalysts are increasingly employed for commercial API synthesis.
/ read more /

FILL/FINISH

Parenteral Advisory: Outmoded Fill/Finish Technology

Improvements to aseptic manufacturing procedures are long overdue. But how feasible is it for manufacturers to modernize fill lines of legacy products?
/ read more /


Upcoming WEBCASTS

From Bench to Clinic: Preclinical and First-in-Man Development Strategies
Live Webinar: Wednesday, January 18 at 1:00pm EST
Register now


Orally Disintegrating Tablets: A Patient-centric Dosage Form
Live Webinar: Wednesday, January 25 at 9:00am EST
Register now


Events

Pharmapack Europe

February 1–2, 2017

IFPAC Annual Meeting

February 27–March 2, 2017

Pittcon 2017

March 5–9, 2017

more events

REFERENCE BOOKS

Pharmaceutical Technology presents its Analytical Testing Resource Guide combo

A compilation of articles in a three-handbook set covering general Analytical Testing and Stability in the manufacture, packaging, storing, and testing of formulated products.
/ Click here /

More Reference Library

eBOOKS

Quality Throughout the Supply Chain

Quality issues can appear at any stage of the bio/pharmaceutical development and manufacturing supply chain. Drug companies must monitor raw materials, suppliers, contract service providers, facilities, manufacturing processes, and production workers. In this e-book, the editors examine current quality issues, and how the industry is addressing quality challenges throughout the supply chain.


contribute | contact editors | CONTACT SALES | subscribe | advertise